140 related articles for article (PubMed ID: 37982167)
1. Interplay between endocannabinoid and endovanilloid mechanisms in fear conditioning.
Briânis RC; Andreotti JP; Moreira FA; Iglesias LP
Acta Neuropsychiatr; 2023 Nov; ():1-10. PubMed ID: 37982167
[TBL] [Abstract][Full Text] [Related]
2. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
3. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA
J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049
[TBL] [Abstract][Full Text] [Related]
4. TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus.
Iglesias LP; Fernandes HB; de Miranda AS; Perez MM; Faccioli LH; Sorgi CA; Bertoglio LJ; Aguiar DC; Wotjak CT; Moreira FA
Neuropharmacology; 2023 Feb; 224():109314. PubMed ID: 36336070
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids and anxiety.
Moreira FA; Wotjak CT
Curr Top Behav Neurosci; 2010; 2():429-50. PubMed ID: 21309120
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?
Moreira FA; Aguiar DC; Terzian AL; Guimarães FS; Wotjak CT
Neuroscience; 2012 Mar; 204():186-92. PubMed ID: 21906661
[TBL] [Abstract][Full Text] [Related]
7. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
8. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
[TBL] [Abstract][Full Text] [Related]
9. CB
Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
11. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.
Almeida V; Levin R; Peres FF; Suiama MA; Vendramini AM; Santos CM; Silva ND; Zuardi AW; Hallak JEC; Crippa JA; Abílio VC
Neuropharmacology; 2019 Sep; 155():44-53. PubMed ID: 31103618
[TBL] [Abstract][Full Text] [Related]
12. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors.
Marinelli S; Di Marzo V; Florenzano F; Fezza F; Viscomi MT; van der Stelt M; Bernardi G; Molinari M; Maccarrone M; Mercuri NB
Neuropsychopharmacology; 2007 Feb; 32(2):298-308. PubMed ID: 16760924
[TBL] [Abstract][Full Text] [Related]
13. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid and vanilloid pathways mediate opposing forms of synaptic plasticity in corticotropin-releasing hormone neurons.
Jamieson BB; Kim JS; Iremonger KJ
J Neuroendocrinol; 2022 Apr; 34(4):e13084. PubMed ID: 35034400
[TBL] [Abstract][Full Text] [Related]
15. Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.
Back FP; Carobrez AP
Neuropharmacology; 2018 Jun; 135():399-411. PubMed ID: 29596901
[TBL] [Abstract][Full Text] [Related]
16. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
Uliana DL; Hott SC; Lisboa SF; Resstel LB
Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
[TBL] [Abstract][Full Text] [Related]
17. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
18. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the Antinociceptive Effect of Local Injections of Anandamide in Mice.
Mascarenhas DC; Gomes KS; Sorregotti T; Nunes-de-Souza RL
Front Pharmacol; 2017; 8():695. PubMed ID: 29046638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
